Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Gerresheimer's strategic shift to value-driven solutions in pharma packaging supports higher margins. Read why investors ...

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity ...

What are the best stocks right now for investors in the cancer drug development space? Seeking Alpha analysts offer their ...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for ...

Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

The German billionaire Christian Angermayer covers his Manhattan penthouse with symbols of his favorite investments. On one wall is a graffiti print of the Bitcoin crest overlaying U.S. dollars; next ...

LADENBURG, Germany I May 27, 2025 I Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...